Sotera Health Company
SHC
$11.06
-$0.13-1.16%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -12.29% | 1.66% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -12.29% | 1.66% | |||
| Cost of Revenue | -5.36% | -1.26% | |||
| Gross Profit | -17.60% | 4.01% | |||
| SG&A Expenses | -2.07% | -4.34% | |||
| Depreciation & Amortization | -0.36% | -0.81% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.10% | -2.05% | |||
| Operating Income | -28.19% | 9.72% | |||
| Income Before Tax | -132.97% | 5.17% | |||
| Income Tax Expenses | -104.79% | 26.73% | |||
| Earnings from Continuing Operations | -207.60% | -27.50% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -207.60% | -27.50% | |||
| EBIT | -28.19% | 9.72% | |||
| EBITDA | -19.67% | 4.55% | |||
| EPS Basic | -207.59% | -27.50% | |||
| Normalized Basic EPS | -48.61% | 8.25% | |||
| EPS Diluted | -214.94% | -27.50% | |||
| Normalized Diluted EPS | -48.14% | 8.24% | |||
| Average Basic Shares Outstanding | 0.11% | 0.07% | |||
| Average Diluted Shares Outstanding | -0.79% | 0.09% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||